Science Explorer Back to mapMap
Discussion
Researcher · Saiseikai Central Hospital · Japan

Morio Nakamura

Morio Nakamura publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Asthma and respiratory diseases.

ORCID 0000-0002-0140-6155 OpenAlex
World rank
#806,781
of 7,710,434 ranked researchers
Rank in Japan
#9,984
of 383,136
Works
133
Citations
5.2k
Citations per work
39.2
h-index
31
i10-index 51Top 8.2% in Pulmonary and Respiratory Medicine
Morio Nakamura

What does Morio Nakamura research?

Morio Nakamura's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 69 works · 51.6% of their workMedicine: 69 works · 51.6% of their workPulmonary and Respiratory Medicine: 29 works · 22.1% of their workOncology: 14 works · 10.5% of their workEpidemiology: 10 works · 7.7% of their workInfectious Diseases: 10 works · 7.2% of their workPhysiology: 5 works · 4.1% of their workEverything else: 57 works · 43.2% of their workLife Sciences: 7 works · 5.2% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 5.2% of their workMolecular Biology: 7 works · 5.2% of their workTHEIR WORKMorio Nakamura133works
Life Sciences5%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine6951.6%
  2. Everything else5743.2%
    1. Biochemistry, Genetics and Molecular Biology75.2%
  1. 1Pulmonary and Respiratory Medicine22% of their works
  2. 2Oncology10% of their works
  3. 3Epidemiology8% of their works
  4. 4Infectious Diseases7% of their works
  5. 5Molecular Biology5% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Morio Nakamura's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Epidemiology, ACE2 Receptor, SARS-CoV-2, ALK Inhibitors, EGFR Mutations and Allergic Diseases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Clinical Trials202 topics
  2. Targeted Therapy202 topics
  3. Epidemiology192 topics
  4. ACE2 Receptor172 topics
  5. SARS-CoV-2172 topics
  6. ALK Inhibitors121 topic
  7. EGFR Mutations121 topic
  8. Allergic Diseases101 topic
  9. Asthma101 topic
  10. Immune Checkpoint Blockade101 topic
  11. PD-1 and PD-L1101 topic
  12. Chronic Cough91 topic
  13. Clinical Characteristics91 topic
  14. Cough Reflex Sensitivity91 topic
  15. Thrombosis91 topic
  16. Coronavirus81 topic
  17. Genomic Profiles81 topic
  18. Neurologic Manifestations81 topic
  19. Post-acute COVID-19 Syndrome81 topic
  20. Small-Cell Lung Cancer81 topic
  21. Vaccine81 topic

Where does Morio Nakamura work?

Morio Nakamura's main affiliation in the publication record is Saiseikai Central Hospital, Japan.

How many publications and citations does Morio Nakamura have?

OpenAlex counts 133 works and 5,220 citations for Morio Nakamura, an h-index of 31, ranking #806,781 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Morio Nakamura. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.